A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification
Condition: C-staged Hepatocellular Carcinoma in BCLC Classification Intervention: Combination Product: Hepatic Arterial Infusion combined with Apatinib and Camrelizumab Sponsors: Sun Yat-sen University; Jiangsu HengRui Medicine Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials